UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): January 22, 2014

                            NEVADA HEALTH SCAN, INC.
                    -----------------------------------------
             (Exact name of registrant as specified in its charter)

         Delaware                      000-54231                 27-4336843
 -------------------------         ------------------         ----------------
(State or other jurisdiction      (Commission File No.)      (IRS Employer
  of incorporation)                                          Identification No.)

                             1550 Larimer, Ste. 264
                                Denver, CO 80202
                  --------------------------------------------
          (Address of principal executive offices, including Zip Code)

            Registrant's telephone number, including area code: None


         (Former name or former address if changed since last report)

Checkappropriate  box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[]  Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

Item 5.02.  Departure   of  Directors   or  Certain   Officers;   Election  of
            Directors;   Appointment   of   Certain   Officers;   Compensatory
            Arrangements of Certain Officers.

     Effective  as of January  22,  2014 Jay  Czarkowski  was  appointed  as the
Company's  Chief  Executive  Officer and a director  and  Benjamin J. Barton was
appointed as the Company's Chief Financial and Accounting Officer.

     Since June,  2012, Mr.  Czarkowski (age 49) has been a managing  partner of
Canna, LLC d/b/a Canna Advisors, a company providing consulting services for the
regulated cannabis industry. In October, 2009, Mr. Czarkowski co-founded Boulder
Kind  Care,  a  company  which  operated  a retail  marijuana  dispensary  and a
marijuana  production  facility  which focused on the  consistent  production of
large amounts of high quality, pharmaceutical-grade marijuana. Boulder Kind Care
was sold in May,  2012.  Between 2003 and 2010 Mr.  Czarkowski  was the managing
partner of  Construction  Design Group,  LLC a residential  and commercial  real
estate development  company in Colorado.  Mr. Czarkowski is a founding member of
the National Cannabis Industry  Association and a sustaining member of Americans
for Safe Access (ASA). Mr. Czarkowski  graduated from Norwich  University with a
Bachelor of Science degree in Electrical Engineering.

     Since 2005 Mr. Barton (age 50) has been the managing  member of SCP, a firm
which provides consulting  services to private and public companies.  Mr. Barton
holds a Bachelor of Science  degree in  Political  Science  from  Arizona  State
University and an MBA degree in finance from UCLA.

     No later than March 22,  2014,  which may be extended by an  additional  30
days by mutual agreement of the parties,  the Company may acquire Canna Advisors
from Mr. Czarkowski, on mutually agreed upon terms and conditions.

     Effective  January  22,  2014,  the  Company  entered  into  an  employment
agreement  with Mr.  Czarkowski.  The agreement has an initial term of two years
and provides that the Company will pay Mr.  Czarkowski  $12,000 per month during
the term of the  agreement.  Pursuant  to the  employment  agreement,  Strategic
Capital Partners, LLC, the Company's largest shareholder,  sold 2,000,000 shares
of the Company's common stock to Mr. Czarkowski at a price of $0.02 per share.

     Of  these  2,000,000  shares,  1,000,000  shares  are  subject  to  vesting
requirements. The vesting schedule for the 1,000,000 shares is as follows:

            Number
            of shares               Vesting Date (1)

           400,000                    7/22/2014
           300,000                    1/22/2015
           300,000                    7/22/2015

(1)  Vesting will occur for the applicable  shares if Mr. Czarkowski is employed
     by the Company on the vesting date.

                                       2
<PAGE>

     Notwithstanding the above, none of the 1,000,000 shares will vest until the
Company completes the acquisition of Canna Advisors.

     If during the term of the employment agreement Mr. Czarkowski is Terminated
other than For Cause, there is a Change in Control, or Mr. Czarkowski terminates
the  employment  agreement for Good Reason,  then,  and provided the Company has
completed  the  acquisition  of Canna  Advisors,  all shares  which have not yet
vested will immediately  vest.  Notwithstanding  the above, the vesting schedule
for the shares will not change if the Company has not completed the  acquisition
of Canna Advisors on the date any of the foregoing events take place.

     All  shares  that  are  not  vested  at  the  time  of  termination  of Mr.
Czarkowski's  employment,  if such  termination is a Termination  for Cause or a
Voluntary  Termination,  will be  repurchased by the Company at a price of $0.02
per share.  Any shares  which are not  vested and which are not  required  to be
purchased by the Company will be returned to treasury and cancelled.

     The Company also granted Mr. Czarkowski options to purchase up to 1,200,000
shares of the Company's common stock. The terms of the options are shown below.

      Shares Issuable
      Upon Exercise               Option
        of Option          Exercise Price   Vesting Date (1)  Expiration Date
      ------------         --------------   ----------------  ---------------

800,000                      $  8.00          1/22/2015         1/22/2018
400,000                       $12.00          7/22/2015         1/22/2018

(1)  The vesting  date is the date the options may first be  exercised.  Vesting
     will occur for the applicable  options if Mr. Czarkowski is employed by the
     Company on the vesting date.

     Notwithstanding  the above,  no options can be exercised  until the Company
completes the  acquisition of Canna  Advisors.  However,  if the  acquisition of
Canna Advisors has been  completed  prior to the  termination of Mr.  Czarkowski
employment  with the Company,  then any options which did not vest due to solely
to the fact that the acquisition of Canna Advisors had not been completed,  will
vest.

     If during the term of the employment agreement Mr. Czarkowski is Terminated
other than For Cause, there is a Change in Control, or Mr. Czarkowski terminates
the  employment  agreement for Good Reason,  then,  and provided the Company has
completed  the  acquisition  of Canna  Advisors,  all options which have not yet
vested will immediately  vest.  Notwithstanding  the above, the vesting schedule
for the options will not change if the Company has not completed the acquisition
of Canna Advisors on the date any of the foregoing events take place.

     If the employment agreement is terminated voluntarily by Mr. Czarkowski, or
if the employment  agreement is terminated by the Company for Cause, the Company
will pay Mr.  Czarkowski,  as his sole and exclusive remedy,  all accrued salary
and vacation pay to the date of termination.

     If the  employment  agreement is  terminated  by the Company other than for
Cause, or if Mr. Czarkowski terminates the employment agreement for Good Reason,
the Company  will pay Mr.  Czarkowski,  as his sole and  exclusive  remedy,  all
accrued salary and vacation pay, to the date of termination, and all salary that
would have been paid through January 22, 2016.

      For purposes of the employment agreement:

         "Cause" is defined as:

           (i)   willful or gross neglect causing material harm to the Company;

           (ii)  willful or gross misconduct or insubordination;

           (iii) the commission of fraud, misappropriation or embezzlement
                 causing harm to the Company;

           (iv)  a material breach of the employment agreement by Mr.
                 Czarkowski; or

           (v)   a conviction or plea of no contest to a felony involving moral
                 turpitude.

         "Change of Control" is defined as:

           (i)   a merger, consolidation or reorganization resulting in the
                 Company's shareholders controlling less than 50% of the
                 successor corporation;

           (ii)  the sale of substantially all of the Company's assets; or

           (iii) the sale of more than 50% of the Company's common stock.

         Termination "for Good Reason" is defined as:

           (i)   the relocation by the Company of Mr. Czarkowski's principal
                 place of employment from Boulder, Colorado;

           (ii)  a material reduction of Mr. Czarkowski's responsibilities and
                 duties;

           (iii) a material breach of the employment agreement by the
                 Company; or

           (iv)  a reduction in Mr. Czarkowski's salary.

                                       3
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: February 24, 2014
                                      NEVADA HEALTH SCAN, INC.


                                      By:/s/ Jay Czarkowski
                                         ---------------------------------
                                          Jay Czarkowski, Chief Executive
                                          Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kitem502apptjayfeb-14.txt", "description": "FORM 8-K ITEM 5.02 APPOINTMENT OF JAY CZARKOWSKI", "secsgml_size_bytes": 10313}]
{"company-data": {"conformed-name": "Nevada Health Scan, Inc.", "cik": "0001508348", "assigned-sic": "6770", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "14647930"}, "business-address": {"street1": "1550 LARIMER", "street2": "SUITE 264", "city": "DENVER", "state": "CO", "zip": "80202", "phone": "(303) 839-0061"}, "mail-address": {"street1": "1550 LARIMER", "street2": "SUITE 264", "city": "DENVER", "state": "CO", "zip": "80202"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): January 22, 2014

                            NEVADA HEALTH SCAN, INC.
                    -----------------------------------------
             (Exact name of registrant as specified in its charter)

         Delaware                      000-54231                 27-4336843
 -------------------------         ------------------         ----------------
(State or other jurisdiction      (Commission File No.)      (IRS Employer
  of incorporation)                                          Identification No.)

                             1550 Larimer, Ste. 264
                                Denver, CO 80202
                  --------------------------------------------
          (Address of principal executive offices, including Zip Code)

            Registrant's telephone number, including area code: None

         (Former name or former address if changed since last report)

Checkappropriate  box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[]  Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
    Exchange Act (17 CFR 240.13e-4(c))
Item 5.02.  Departure   of  Directors   or  Certain   Officers;   Election  of
            Directors;   Appointment   of   Certain   Officers;   Compensatory
            Arrangements of Certain Officers.

     Effective  as of January  22,  2014 Jay  Czarkowski  was  appointed  as the
Company's  Chief  Executive  Officer and a director  and  Benjamin J. Barton was
appointed as the Company's Chief Financial and Accounting Officer.

     Since June,  2012, Mr.  Czarkowski (age 49) has been a managing  partner of
Canna, LLC d/b/a Canna Advisors, a company providing consulting services for the
regulated cannabis industry. In October, 2009, Mr. Czarkowski co-founded Boulder
Kind  Care,  a  company  which  operated  a retail  marijuana  dispensary  and a
marijuana  production  facility  which focused on the  consistent  production of
large amounts of high quality, pharmaceutical-grade marijuana. Boulder Kind Care
was sold in May,  2012.  Between 2003 and 2010 Mr.  Czarkowski  was the managing
partner of  Construction  Design Group,  LLC a residential  and commercial  real
estate development  company in Colorado.  Mr. Czarkowski is a founding member of
the National Cannabis Industry  Association and a sustaining member of Americans
for Safe Access (ASA). Mr. Czarkowski  graduated from Norwich  University with a
Bachelor of Science degree in Electrical Engineering.

     Since 2005 Mr. Barton (age 50) has been the managing  member of SCP, a firm
which provides consulting  services to private and public companies.  Mr. Barton
holds a Bachelor of Science  degree in  Political  Science  from  Arizona  State
University and an MBA degree in finance from UCLA.

     No later than March 22,  2014,  which may be extended by an  additional  30
days by mutual agreement of the parties,  the Company may acquire Canna Advisors
from Mr. Czarkowski, on mutually agreed upon terms and conditions.

     Effective  January  22,  2014,  the  Company  entered  into  an  employment
agreement  with Mr.  Czarkowski.  The agreement has an initial term of two years
and provides that the Company will pay Mr.  Czarkowski  $12,000 per month during
the term of the  agreement.  Pursuant  to the  employment  agreement,  Strategic
Capital Partners, LLC, the Company's largest shareholder,  sold 2,000,000 shares
of the Company's common stock to Mr. Czarkowski at a price of $0.02 per share.

     Of  these  2,000,000  shares,  1,000,000  shares  are  subject  to  vesting
requirements. The vesting schedule for the 1,000,000 shares is as follows:

            Number
            of shares               Vesting Date (1)

           400,000                    7/22/2014
           300,000                    1/22/2015
           300,000                    7/22/2015

(1)  Vesting will occur for the applicable  shares if Mr. Czarkowski is employed
     by the Company on the vesting date.

                                       2
Notwithstanding the above, none of the 1,000,000 shares will vest until the
Company completes the acquisition of Canna Advisors.

     If during the term of the employment agreement Mr. Czarkowski is Terminated
other than For Cause, there is a Change in Control, or Mr. Czarkowski terminates
the  employment  agreement for Good Reason,  then,  and provided the Company has
completed  the  acquisition  of Canna  Advisors,  all shares  which have not yet
vested will immediately  vest.  Notwithstanding  the above, the vesting schedule
for the shares will not change if the Company has not completed the  acquisition
of Canna Advisors on the date any of the foregoing events take place.

     All  shares  that  are  not  vested  at  the  time  of  termination  of Mr.
Czarkowski's  employment,  if such  termination is a Termination  for Cause or a
Voluntary  Termination,  will be  repurchased by the Company at a price of $0.02
per share.  Any shares  which are not  vested and which are not  required  to be
purchased by the Company will be returned to treasury and cancelled.

     The Company also granted Mr. Czarkowski options to purchase up to 1,200,000
shares of the Company's common stock. The terms of the options are shown below.

      Shares Issuable
      Upon Exercise               Option
        of Option          Exercise Price   Vesting Date (1)  Expiration Date
      ------------         --------------   ----------------  ---------------

800,000                      $  8.00          1/22/2015         1/22/2018
400,000                       $12.00          7/22/2015         1/22/2018

(1)  The vesting  date is the date the options may first be  exercised.  Vesting
     will occur for the applicable  options if Mr. Czarkowski is employed by the
     Company on the vesting date.

     Notwithstanding  the above,  no options can be exercised  until the Company
completes the  acquisition of Canna  Advisors.  However,  if the  acquisition of
Canna Advisors has been  completed  prior to the  termination of Mr.  Czarkowski
employment  with the Company,  then any options which did not vest due to solely
to the fact that the acquisition of Canna Advisors had not been completed,  will
vest.

     If during the term of the employment agreement Mr. Czarkowski is Terminated
other than For Cause, there is a Change in Control, or Mr. Czarkowski terminates
the  employment  agreement for Good Reason,  then,  and provided the Company has
completed  the  acquisition  of Canna  Advisors,  all options which have not yet
vested will immediately  vest.  Notwithstanding  the above, the vesting schedule
for the options will not change if the Company has not completed the acquisition
of Canna Advisors on the date any of the foregoing events take place.

     If the employment agreement is terminated voluntarily by Mr. Czarkowski, or
if the employment  agreement is terminated by the Company for Cause, the Company
will pay Mr.  Czarkowski,  as his sole and exclusive remedy,  all accrued salary
and vacation pay to the date of termination.

     If the  employment  agreement is  terminated  by the Company other than for
Cause, or if Mr. Czarkowski terminates the employment agreement for Good Reason,
the Company  will pay Mr.  Czarkowski,  as his sole and  exclusive  remedy,  all
accrued salary and vacation pay, to the date of termination, and all salary that
would have been paid through January 22, 2016.

      For purposes of the employment agreement:

         "Cause" is defined as:

           (i)   willful or gross neglect causing material harm to the Company;

           (ii)  willful or gross misconduct or insubordination;

           (iii) the commission of fraud, misappropriation or embezzlement
                 causing harm to the Company;

           (iv)  a material breach of the employment agreement by Mr.
                 Czarkowski; or

           (v)   a conviction or plea of no contest to a felony involving moral
                 turpitude.

         "Change of Control" is defined as:

           (i)   a merger, consolidation or reorganization resulting in the
                 Company's shareholders controlling less than 50% of the
                 successor corporation;

           (ii)  the sale of substantially all of the Company's assets; or

           (iii) the sale of more than 50% of the Company's common stock.

         Termination "for Good Reason" is defined as:

           (i)   the relocation by the Company of Mr. Czarkowski's principal
                 place of employment from Boulder, Colorado;

           (ii)  a material reduction of Mr. Czarkowski's responsibilities and
                 duties;

           (iii) a material breach of the employment agreement by the
                 Company; or

           (iv)  a reduction in Mr. Czarkowski's salary.

                                       3
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: February 24, 2014
                                      NEVADA HEALTH SCAN, INC.

                                      By:/s/ Jay Czarkowski
                                         ---------------------------------
                                          Jay Czarkowski, Chief Executive
                                          Officer